Dendritic cells capture antigens from cancer cells, process them, and present the processed antigens on their surface using major histocompatibility complex (MHC) molecules. This antigen presentation is essential for the activation of T-cells, which are critical for the adaptive immune response. By presenting these antigens, DCs help to educate T-cells about the presence of cancer cells, thereby stimulating a targeted immune response against the tumor.
